GMPS and pancreatic ductal adenocarcinoma: It was shown that the metabolic syndrome-related gene guanosine monophosphate synthetase (GMPS) could predict prognosis in pancreatic ductal adenocarcinoma (PDAC) (Cai et al., 2021).